DCIS and LCIS: Are the Risk Factors for Developing In Situ Breast Cancer Different? by Jasmine Timbres, Kelly Kohut, Michele Caneppele, Maria Troy, Marjanka K. Schmidt, Rebecca Roylance, Elinor Sawyer

Get full text

Corrigendum to “The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer” [Breast 52 (2020)... by Mark van Barele, Bernadette A.M. Heemskerk-Gerritsen, Helena C. van Doorn, Marjanka K. Schmidt, Maartje J. Hooning, Agnes Jager

Get full text

Worse breast cancer prognosis of BRCA1/BRCA2 mutation carriers: what's the evidence? A systematic review with meta-analysis. by Alexandra J van den Broek, Marjanka K Schmidt, Laura J van 't Veer, Rob A E M Tollenaar, Flora E van Leeuwen

Get full text

The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of un... by Maartje A.C. Schreurs, Teresa Ramón y Cajal, Muriel A. Adank, J. Margriet Collée, Antoinette Hollestelle, Jeroen van Rooij, Marjanka K. Schmidt, Maartje J. Hooning

Get full text

Diabetes and Breast Cancer Subtypes. by Heleen K Bronsveld, Vibeke Jensen, Pernille Vahl, Marie L De Bruin, Sten Cornelissen, Joyce Sanders, Anssi Auvinen, Jari Haukka, Morten Andersen, Peter Vestergaard, Marjanka K Schmidt

Get full text

Breast cancer risk factors and their effects on survival: a Mendelian randomisation study by Maria Escala-Garcia, Anna Morra, Sander Canisius, Jenny Chang-Claude, Siddhartha Kar, Wei Zheng, Stig E. Bojesen, Doug Easton, Paul D. P. Pharoah, Marjanka K. Schmidt

Get full text

The association of diabetes mellitus and insulin treatment with expression of insulin-related proteins in breast tumors by Heleen K. Bronsveld, Marie L. De Bruin, Jelle Wesseling, Joyce Sanders, Ingrid Hofland, Vibeke Jensen, Marloes T. Bazelier, Bas ter Braak, Anthonius de Boer, Peter Vestergaard, Marjanka K. Schmidt

Get full text

Evaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients. by Marcelo Sobral-Leite, Esther H Lips, Hayra de Andrade Vieira-Monteiro, Letícia Carlos Giacomin, Daniely Regina Freitas-Alves, Sten Cornelissen, Lennart Mulder, Jelle Wesseling, Marjanka K Schmidt, Rosane Vianna-Jorge

Get full text

Data describing the poor outcome associated with a breast cancer diagnosis in the post-weaning period by Hanne Lefrère, Giuseppe Floris, Marjanka K. Schmidt, Patrick Neven, Ellen Warner, Elyce Cardonick, Fedro Alessandro Peccatori, Sibylle Loibl, Charlotte Maggen, Hanne De Mulder, Katarzyna J. Jerzak, Diether Lambrechts, Liesbeth Lenaerts, Frédéric Amant

Get full text

Agreement on risk assessment and chemotherapy recommendations among breast cancer specialists: A survey within the MINDACT cohort by Josephine M.N. Lopes Cardozo, Sherylene E. Veira, Laila Ait Hassou, Aimé Lambert Uwimana, Ivana Božović-Spasojević, Jan Bogaerts, Fatima Cardoso, Marjanka K. Schmidt, Emiel J.T. Rutgers, Coralie Poncet, Caroline A. Drukker

Get full text

Risk of metachronous contralateral breast cancer in patients with primary invasive lobular breast cancer: Results from a nationwide cohort by Delal Akdeniz, Iris Kramer, Carolien H. M. vanDeurzen, Bernadette A. M. Heemskerk‐Gerritsen, Michael Schaapveld, Pieter J. Westenend, Adri C. Voogd, Agnes Jager, Ewout W. Steyerberg, Stefan Sleijfer, Marjanka K. Schmidt, Maartje J. Hooning

Get full text

The impact of patient characteristics and lifestyle factors on the risk of an ipsilateral event after a primary DCIS: A systematic review by Sena Alaeikhanehshir, Ellen G. Engelhardt, Frederieke H. van Duijnhoven, Maartje van Seijen, Patrick A. Bhairosing, Donna Pinto, Deborah Collyar, Elinor Sawyer, Shelley E. Hwang, Alastair M. Thompson, Jelle Wesseling, Esther H. Lips, Marjanka K. Schmidt

Get full text

An information-theoretic analysis of genetics, gender and age in cancer patients. by Gurinder Singh Atwal, Raúl Rabadán, Guillermina Lozano, Louise C Strong, Mariëlle W G Ruijs, Marjanka K Schmidt, Laura J van't Veer, Heli Nevanlinna, Johanna Tommiska, Kristiina Aittomäki, Gaelle Bougeard, Thierry Frebourg, Arnold J Levine, Gareth L Bond

Get full text

Prediction Models and Decision Aids for Women with Ductal Carcinoma In Situ: A Systematic Literature Review by Renée S. J. M. Schmitz, Erica A. Wilthagen, Frederieke van Duijnhoven, Marja van Oirsouw, Ellen Verschuur, Thomas Lynch, Rinaa S. Punglia, E. Shelley Hwang, Jelle Wesseling, Marjanka K. Schmidt, Eveline M. A. Bleiker, Ellen G. Engelhardt, Grand Challenge PRECISION Consortium

Get full text

An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation by Francisco J. Candido dos Reis, Gordon C. Wishart, Ed M. Dicks, David Greenberg, Jem Rashbass, Marjanka K. Schmidt, Alexandra J. van den Broek, Ian O. Ellis, Andrew Green, Emad Rakha, Tom Maishman, Diana M. Eccles, Paul D. P. Pharoah

Get full text

Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes by Marcelo Sobral-Leite, Izhar Salomon, Mark Opdam, Dinja T. Kruger, Karin J. Beelen, Vincent van der Noort, Ronald L. P. van Vlierberghe, Erik J. Blok, Daniele Giardiello, Joyce Sanders, Koen Van de Vijver, Hugo M. Horlings, Peter J. K. Kuppen, Sabine C. Linn, Marjanka K. Schmidt, Marleen Kok

Get full text

Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile by Marcel Smid, Marjanka K. Schmidt, Wendy J. C. Prager-van der Smissen, Kirsten Ruigrok-Ritstier, Maartje A. C. Schreurs, Sten Cornelissen, Aida Marsal Garcia, Annegien Broeks, A. Mieke Timmermans, Anita M. A. C. Trapman-Jansen, J. Margriet Collée, Muriel A. Adank, Maartje J. Hooning, John W. M. Martens, Antoinette Hollestelle

Get full text

Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study by Delal Akdeniz, Mark van Barele, Bernadette A.M. Heemskerk-Gerritsen, Ewout W. Steyerberg, Michael Hauptmann, Irma van de Beek, Klaartje van Engelen, Marijke R. Wevers, Encarnacion B. Gómez García, Margreet G.E.M. Ausems, Lieke P.V. Berger, Christi J. van Asperen, Muriel A. Adank, Margriet J. Collée, Denise J. Stommel-Jenner, Agnes Jager, Marjanka K. Schmidt, Maartje J. Hooning

Get full text

Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival by Marcelo Sobral-Leite, Koen Van de Vijver, Magali Michaut, Rianne van der Linden, Gerrit K.J. Hooijer, Hugo M. Horlings, Tesa M. Severson, Anna Marie Mulligan, Nayana Weerasooriya, Joyce Sanders, Annuska M Glas, Diederik Wehkamp, Lorenza Mittempergher, Kelly Kersten, Ashley Cimino-Mathews, Dennis Peters, Erik Hooijberg, Annegien Broeks, Marc J. van de Vijver, Rene Bernards, Irene L. Andrulis, Marleen Kok, Karin E. de Visser, Marjanka K. Schmidt

Get full text

Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status by Yuwei Wang, Gwen M. H. E. Dackus, Efraim H. Rosenberg, Sten Cornelissen, Leonora W. de Boo, Annegien Broeks, Wim Brugman, Terry W. S. Chan, Paul J. van Diest, Michael Hauptmann, Natalie D. ter Hoeve, Olga I. Isaeva, Vincent M. T. de Jong, Katarzyna Jóźwiak, Roelof J. C. Kluin, Marleen Kok, Esther Koop, Petra M. Nederlof, Mark Opdam, Philip C. Schouten, Sabine Siesling, Charlaine van Steenis, Adri C. Voogd, Willem Vreuls, Roberto F. Salgado, Sabine C. Linn, Marjanka K. Schmidt

Get full text